Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
Cboe Canada
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Market Movers
Bonds
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Thematic Insights
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Options
|
Price History
|
Ratios
|
Ownership
|
Insiders
|
Valuation
Bullboard - Stock Discussion Forum
Antibe Therapeutics Inc(Pre-Merger)
ATBPF
Healthcare
Antibe Therapeutics Inc. is a clinical-stage biotechnology company. The Company is leveraging its hydrogen sulfide (H2S) platform to develop therapies to target inflammation arising from a range of medical conditions. The Company’s pipeline includes assets that seek to overcome the gastrointestinal ulcers and bleeding associated with nonsteroidal anti-inflammatory drugs (NSAIDs). Its lead drug,...
otenaproxesul, is in clinical development as an alternative to opioids and NSAIDs for acute pain. Its second pipeline drug, ATB-352, is being developed for a specialized pain indication. The Company also focuses on inflammatory bowel disease (IBD). Otenaproxesul combines a moiety that releases hydrogen sulfide with naproxen, a non-steroidal, anti-inflammatory drug. ATB-352 is an H2S-releasing derivative of ketoprofen, a potent NSAID commonly prescribed for acute pain. Its IBD candidates are being designed to maintain the efficacy, safety, and pharmacokinetic properties of ATB-429.
see more
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Add To Watchlist
Bullboard (GREY:ATBPF)
New Post
View:
Posts & Comments
Threaded Posts
Prev
...
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
...
Next
(450)
•••
davgro
X
View Profile
View Bullboard History
Post by
davgro
on Feb 22, 2023 11:51am
ATE - Next Entry Point C$ 0.45 or Lower
I have been on the sidelines since mid January watching for the next ATE entry point. I now see a slow decline in the stock share price into the low to mid C$ 0.40s. That could be my entry point
...more
(1093)
•••
Duster340
X
View Profile
View Bullboard History
Post by
Duster340
on Feb 22, 2023 11:23am
Looks Like
selling has become exhausted. everyday that goes by is a day closer to the start of P2. the longer investors wait the higher the entry price becomes. glta
(379)
•••
Benedictus
X
View Profile
View Bullboard History
Comment by
Benedictus
on Feb 17, 2023 10:14pm
RE:RE:Cheap ATE Shares
The mid .50s shelf needs to hold or we will likely see a re-test the mid to lower 40's again. The pushed out p2 timeline resulted in some selling understandably but so far the weekly chart
...more
(1093)
•••
Duster340
X
View Profile
View Bullboard History
Post by
Duster340
on Feb 17, 2023 4:49pm
Today was a good day
some buying of the stock flat on the day. the blackout period is off next week, could see some insider buying soon.
(1093)
•••
Duster340
X
View Profile
View Bullboard History
Comment by
Duster340
on Feb 17, 2023 4:39pm
RE:RE:Cheap ATE Shares
Liar, i remeber when you said you bought the share. ate was in the 70,s at the time, the truth is you either sold at a loss or you still own and are underwater.
(450)
•••
davgro
X
View Profile
View Bullboard History
Comment by
davgro
on Feb 17, 2023 1:24pm
RE:Cheap ATE Shares
Sold my entire ATE position on January 17th @ C$0.64 (average) for a respectable 33% return. I have been sitting on the sidelines ever since just watching trading activity and updatres from the
...more
(1093)
•••
Duster340
X
View Profile
View Bullboard History
Post by
Duster340
on Feb 17, 2023 10:31am
Picked up some more
@56 thanks
(1093)
•••
Duster340
X
View Profile
View Bullboard History
Post by
Duster340
on Feb 16, 2023 1:06pm
$2.00 Price Target
Naz Rahman Buy $2.00 Maxim Group 15 Feb 2023
(1093)
•••
Duster340
X
View Profile
View Bullboard History
Comment by
Duster340
on Feb 15, 2023 11:49pm
RE:RE:A Little Disappointed
i think you misread Dr.Wallace has not jumped ship yet, he still is with the company. Dr. John L. Wallace, has decided to retire from the Board of Directors. Dr. Wallace will remain a corporate
...more
(257)
•••
fox7mf
X
View Profile
View Bullboard History
Comment by
fox7mf
on Feb 15, 2023 1:46pm
RE:A Little Disappointed
More delays. That's all this biotech is about now. Wallace retiring as well...jumping from a sinking ship? What say you Marky1 and Mugs? Does Ate ever bounce back?
(1093)
•••
Duster340
X
View Profile
View Bullboard History
Post by
Duster340
on Feb 15, 2023 10:45am
Partial Order
filled @58 this morning, hopeing the rest gets filled. i think 58 cents is a very good buy. what will the price be a year from now? most of us have already been waiting 2 years or more, whats another
...more
(1093)
•••
Duster340
X
View Profile
View Bullboard History
Post by
Duster340
on Feb 15, 2023 9:19am
Predictable Delays
but the update is very promising, i do not think the stock will go lower, it already is priced dirt cheap. if there is a dip i am sure it will be bought up imediatley. i will be a buyer #1 burnt
...more
(0)
•••
PressRelease
X
View Profile
View Bullboard History
Post by
PressRelease
on Feb 15, 2023 7:03am
New Press Release - Antibe Reports Q3 2023 Interim Financial and Operating Results
- Recent animal data on otenaproxesul's new formulation confirm rapid drug uptake and potential for effective pain management - Targeting first clinical dose in calendar Q3 2023; Phase II top-line data within 12 months - Ended quarter with $42.4 million in cash and equivalents, providing...
read article.
(37)
•••
TheMadMonk
X
View Profile
View Bullboard History
Post by
TheMadMonk
on Feb 14, 2023 8:27pm
A Little Disappointed
The new anticipated start date for the Phase II bunionectomy trial is now calendar Q4 2023. On the plus side this gives me more time to continue to average down since there does not
...more
(1093)
•••
Duster340
X
View Profile
View Bullboard History
Post by
Duster340
on Feb 14, 2023 11:42am
No Interest
i thought there might be some buying today? but maybe investors are leaning more towards selling than buying, could be they have lost all confidence and trust in the company. investors might be
...more
Prev
...
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
...
Next
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
The Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >
A daily snapshot of everything
from market open to close.
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}
{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >